SLC5A2 and type 2 diabetes mellitus: Additionally, SGLT2 inhibitors increase the production of brain-derived neurotrophic factor (BDNF), a regulator of synaptogenesis and synaptic plasticity that is often reduced in T2DM but is believed to be essential for learning and memory [167].